Acquisitions · Pharmaceuticals (generic injectables)
Nichi-Iko buys US generic injectables maker Sagent for about $736 million
- Buyer
- Nichi-Iko Pharmaceutical (Toyama)
- Target
- Sagent Pharmaceuticals, Schaumburg, Illinois
- Value
- About $736M total consideration (all-cash tender offer)
- Status
- Agreed on July 10, 2016; completed in 2016.
- Date
- 2016-07-11
Nichi-Iko Pharmaceutical agreed to buy Sagent Pharmaceuticals of Schaumburg, Illinois, a supplier of generic injectable drugs, through an all-cash tender offer. The total consideration was about $736 million.
Why it matters
The deal gives Nichi-Iko a sales base in the US generic drug market as price cuts squeeze generic makers at home.
Sources
Kakehashi M&A News home
